Predict your next investment

Venture Capital
artisventures.com

See what CB Insights has to offer

Investments

72

Portfolio Exits

11

Funds

15

Service Providers

2

About Artis Ventures

Artis Ventures passionately supports and partners with entrepreneurs who are driven to positively impact their world through disruptive technological innovation.

Artis Ventures Headquarter Location

988 Market Street

San Francisco, California, 94102,

United States

415-344-6200

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Artis Ventures

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Artis Ventures in 5 Expert Collections, including Synthetic Biology.

S

Synthetic Biology

382 items

P

Pharma Startups

5,090 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

F

Fitness Tech

227 items

We define fitness tech as companies leveraging software and technology to augment approaches to developing or maintaining physical fitness. Companies in this category develop tools and services including workout apps, wearables, and connected fitness equipment.

M

Microbiome

105 items

I

Industrial SynBio

382 items

Synthetic biology focused on replacing industrial and commercial materials.

Latest Artis Ventures News

Activ Surgical secures $45 million in Series B funding led by Cota Capital

Oct 18, 2021

October 18, 2021 Activ Surgical , a digital surgery pioneer, has raised $45 million in a Series B financing round. The Series B round was led by Cota Capital, a multi-stage investment firm focused on private and public modern enterprise technology companies. Seven new investors, including BAM Funds, Magnetar Capital, Mint Ventures, Castor Ventures, Dream One Vision and Nvidia, join existing investors DNS Capital,Tao Capital Partners, LRVHealth, Rising Tide VC, GreatPoint Ventures and ARTIS Ventures to close out the Series B round of financing. To date, Activ Surgical has raised a total of $77 million. Activ Surgical is building a hardware-agnostic platform, including the recently announced ActivInsights augmented reality-based software suite, to enable autonomous and collaborative surgery through the integration of computer vision, artificial intelligence, machine learning, AR and robotics. The company will use this Series B financing round to support the commercial availability of the ActivInsights software suite, including the first Insight – an AR-based overlay that displays tissue perfusion in real time without the use of traditional dyes. Activ Surgical will also use the funds to support commercialization in the US, pursue a CE mark in support of the global rollout and further enhance the ActivInsights software platform and to develop its first ML-based insights. In conjunction with this fundraise, the Activ Surgical board of directors will expand to include Bobby Yazdani, founder and partner from Cota Capital. Yazdani has more than three decades of entrepreneurial experience, including 20+ years of investing in technology companies, in Silicon Valley and formed Cota Capital in 2014. Yazdani will serve on Activ Surgical’s Board of Directors alongside current board members Ameena El-Bibany, ARTIS Ventures; Will Cowen, LRVHealth; Emily Casey, DNS Capital; Ashok Krishnamurthi, Great Point Ventures; Paul Meister, Independent Board Member; Dr Peter Kim, Activ Surgical; and Todd Usen, Activ Surgical. Yazdani says: “Activ Surgical is on pace to solve the ‘last mile’ challenge for the surgical field and revolutionize the operating room as we know it. “The company’s cutting-edge product portfolio, coupled with its talented and experienced leadership team and staff, has the potential to deliver world class surgery, regardless of geography or economic status, while helping to save lives and reduce medical complications. “We are thrilled to be the lead investor on this Series B fundraise and are excited about what the future holds for the company and its technology.” Todd Usen, CEO, Activ Surgical, says: “2021 continues to be a critical year for Activ Surgical as we are laser focused on democratizing surgical care at the global level. “We received FDA clearance for our ActivSight enhanced visualization module that will power the ActivInsights software suite, and were issued our first US patent for ActivSight, as well as completed our first in-human clinical trials and have grown our team by 35 percent. “The addition of seven new investors spanning the medical and technology industries is a wonderful testament to our team’s vision and work to-date. We are thrilled to be supported by this diverse group of investors, and we welcome Bobby to our Board as we look to make our ActivInsights software suite commercially available in 2022.” Renee Yao, global healthcare AI startups lead at Nvidia, says: ​​“Activ Surgical is on a mission to empower surgeons with the critical information they need. “Their team is fusing together technologies to enable real-time intelligence and visualization for the operating room of the future.” Share this:

Artis Ventures Investments

72 Investments

Artis Ventures has made 72 investments. Their latest investment was in Delix Therapeutics as part of their Series A on September 9, 2021.

CBI Logo

Artis Ventures Investments Activity

investments chart

Artis Ventures Portfolio Exits

11 Portfolio Exits

Artis Ventures has 11 portfolio exits. Their latest portfolio exit was Lemonaid on October 22, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

10/22/2021

Acquired

$991

22

12/17/2020

Acquired

3

1/29/2020

Merger

1

00/00/0000

Subscribe to see more

Subscribe to see more

$991

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

Date

10/22/2021

12/17/2020

1/29/2020

00/00/0000

00/00/0000

Exit

Acquired

Acquired

Merger

Subscribe to see more

Subscribe to see more

Companies

Subscribe to see more

Subscribe to see more

Valuation

$991

$991

Acquirer

Subscribe to see more

Subscribe to see more

Sources

22

3

1

10

10

Artis Ventures Fund History

15 Fund Histories

Artis Ventures has 15 funds, including Artis Ventures XIV SPV.

Closing Date

Fund

Fund Type

Status

Amount

Sources

9/17/2020

Artis Ventures XIV SPV

$7.4M

1

5/26/2020

Artis Ventures III

Multi-Stage Venture Capital

$89.2M

2

11/16/2017

Artis Ventures XIII SPV

$7.74M

2

4/4/2017

Artis Vindicasse SPV

Subscribe to see more

$99M

10

12/14/2016

Artis Ventures XI SPV

Subscribe to see more

$99M

10

Closing Date

9/17/2020

5/26/2020

11/16/2017

4/4/2017

12/14/2016

Fund

Artis Ventures XIV SPV

Artis Ventures III

Artis Ventures XIII SPV

Artis Vindicasse SPV

Artis Ventures XI SPV

Fund Type

Multi-Stage Venture Capital

Subscribe to see more

Subscribe to see more

Status

Amount

$7.4M

$89.2M

$7.74M

$99M

$99M

Sources

1

2

2

10

10

Artis Ventures Service Providers

2 Service Providers

Artis Ventures has 2 service provider relationships

Service Provider

Associated Rounds

Provider Type

Service Type

Counsel

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Service Provider

Subscribe to see more

Associated Rounds

Subscribe to see more

Provider Type

Counsel

Subscribe to see more

Service Type

Subscribe to see more

Partnership data by VentureSource

Artis Ventures Team

5 Team Members

Artis Ventures has 5 team members, including current Founder, Managing General Partner, Stuart Peterson.

Name

Work History

Title

Status

Stuart Peterson

Founder, Managing General Partner

Current

Robert Riemer

Chief Operating Officer

Current

Dennis Pattillo

Controller

Current

Vasudev Bailey

General Partner, Senior Partner

Current

Michael Dimitruk

Chief Operating Officer

Former

Name

Stuart Peterson

Robert Riemer

Dennis Pattillo

Vasudev Bailey

Michael Dimitruk

Work History

Title

Founder, Managing General Partner

Chief Operating Officer

Controller

General Partner, Senior Partner

Chief Operating Officer

Status

Current

Current

Current

Current

Former

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.